HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Noninvasive positive pressure ventilation using a helmet in patients with acute exacerbation of chronic obstructive pulmonary disease: a feasibility study.

AbstractBACKGROUND:
Noninvasive positive pressure ventilation (NPPV) with a facemask (FM) is effective in patients with acute exacerbation of their chronic obstructive pulmonary disease. Whether it is feasible to treat these patients with NPPV delivered by a helmet is not known.
METHODS:
Over a 4-month period, the authors studied 33 chronic obstructive pulmonary disease patients with acute exacerbation who were admitted to four intensive care units and treated with helmet NPPV. The patients were compared with 33 historical controls treated with FM NPPV, matched for simplified acute physiologic score (SAPS II), age, PaCO2, pH, and PaO2:fractional inspired oxygen tension. The primary endpoints were the feasibility of the technique, improvement of gas exchange, and need for intubation.
RESULTS:
The baseline characteristics of the two groups were similar. Ten patients in the helmet group and 14 in the FM group (P = 0.22) were intubated. In the helmet group, no patients were unable to tolerate NPPV, whereas five patients required intubation in the FM group (P = 0.047). After 1 h of treatment, both groups had a significant reduction of PaCO2 with improvement of pH; PaCO2 decreased less in the helmet group (P = 0.01). On discontinuing support, PaCO2 was higher (P = 0.002) and pH lower (P = 0.02) in the helmet group than in the control group. One patient in the helmet group, and 12 in the FM group, developed complications related to NPPV (P < 0.001). Length of intensive care unit stay, intensive care unit, and hospital mortality were similar in both groups.
CONCLUSIONS:
Helmet NPPV is feasible and can be used to treat chronic obstructive pulmonary disease patients with acute exacerbation, but it does not improve carbon dioxide elimination as efficiently as does FM NPPV.
AuthorsMassimo Antonelli, Mariano Alberto Pennisi, Paolo Pelosi, Cesare Gregoretti, Vincenzo Squadrone, Monica Rocco, Luca Cecchini, Davide Chiumello, Paolo Severgnini, Rodolfo Proietti, Paolo Navalesi, Giorgio Conti
JournalAnesthesiology (Anesthesiology) Vol. 100 Issue 1 Pg. 16-24 (Jan 2004) ISSN: 0003-3022 [Print] United States
PMID14695719 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Carbon Dioxide
Topics
  • Acidosis, Respiratory (physiopathology)
  • Acute Disease
  • Aged
  • Carbon Dioxide (blood, metabolism)
  • Endpoint Determination
  • Feasibility Studies
  • Female
  • Humans
  • Intubation, Intratracheal
  • Male
  • Masks
  • Monitoring, Physiologic
  • Positive-Pressure Respiration (instrumentation)
  • Pulmonary Disease, Chronic Obstructive (complications, therapy)
  • Respiratory Function Tests
  • Treatment Outcome
  • Ventilator Weaning

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: